Hair regrowth treatment

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Hair regrowth treatment
Generic name
MINOXIDIL
Manufacturer
Guangzhou Jianyuan Biological Technology.Co.,Ltd
Product type
HUMAN OTC DRUG
SPL set ID
eb87ff2d-7708-4c4d-e053-2a95a90ac72b
SPL ID
529d3660-75b4-6036-e063-6294a90a3170
Version
4
Effective date
2026-05-24
Source export date
2026-09-28
Source partition
14
Source file
https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:39:48
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

For external use only. Extremely Flammable: Avoid fire, flame, or smoking during and immediately following application. May be harmful if used when pregnant or breast-feeding.

warnings and cautions

When using this product do not apply on other parts of the body avoid contact with the eyes. In case of accidental contact, rinse eyes with large amounts of cool tap water. some people have experienced changes in hair color and/or texture it takes time to regrow hair. Results may occur at 2 months with twice a day usage.For some men, youmay need to use this product for at least 4 months before you see results. the amount of hair regrowth is different for each person. This product will not work for all men and women

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.